Prime Medicine considers focus on autoimmune diseases for CAR-T, CEO says

Lei Lei Wu

News Reporter

Prime Medicine is considering developing cell therapies for autoimmune diseases and will likely look for a partner for cancer cell therapies, CEO Keith Gottesdiener said …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Prime Medicine considers focus on autoimmune diseases for CAR-T, CEO says

Lei Lei Wu

News Reporter

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Stem cell startup spun out of George Church’s lab raises $75M

FDA rejects Vanda’s treatment for digestion condition, company rebukes agency's actions

Here's what today's Fed rate cut means for biotech, pharma and venture capital

Upstream Bio files for IPO in sign of life for biotech public offerings

Edgewise’s stock surges as heart drug passes early safety test

Breaking down silos with a new quantitative approach to drug development

Prime Med­i­cine con­sid­ers fo­cus on au­toim­mune dis­eases for CAR-T, CEO says

News Reporter

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Prime Medicine considers focus on autoimmune diseases for CAR-T, CEO says